InvestorsHub Logo
Followers 11
Posts 690
Boards Moderated 0
Alias Born 11/24/2015

Re: None

Wednesday, 05/03/2023 7:59:43 PM

Wednesday, May 03, 2023 7:59:43 PM

Post# of 462242
One headline today... "Eli Lilly adds $23B in market cap as investors rush on promise that this will be the amyloid Alzheimer's drug that works"

Doubt any of us are surprised Lilly has the bit in their teeth and are plowing forward to gain approval of their amyloid tau removal infusion therapy. They've even served notice on the FDA when they expect to gain approval and further indicated government agencies will pony up for the Medicare and Medicaid costs. It's great to be King.

On the plus side of the ledger, we small ankle biters, who hold investments in Anavex, just saw our financial prospects brighten considerably. Big Pharma hates loose ends. If there's even a whiff our small biotech's AD treatment is a serious threat to Amyloid treatment dogma, the odds we're acquired go up dramatically.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News